Skip to main content

Peer Review reports

From: A remarkable response to pazopanib, despite recurrent liver toxicity, in a patient with a high grade endometrial stromal sarcoma, a case report

Original Submission
14 Sep 2016 Submitted Original manuscript
21 Sep 2016 Author responded Author comments - Arie Jan Verschoor
Resubmission - Version 2
21 Sep 2016 Submitted Manuscript version 2
17 Jun 2017 Author responded Author comments - Arie Jan Verschoor
15 Feb 2017 Reviewed Reviewer Report - Ryan Hansen
6 May 2017 Reviewed Reviewer Report - Samuel J. Klempner
Resubmission - Version 3
17 Jun 2017 Submitted Manuscript version 3
1 Oct 2017 Author responded Author comments - Arie Jan Verschoor
1 Jul 2017 Reviewed Reviewer Report - Samuel J. Klempner
Resubmission - Version 4
1 Oct 2017 Submitted Manuscript version 4
20 Dec 2017 Author responded Author comments - Arie Jan Verschoor
Resubmission - Version 5
20 Dec 2017 Submitted Manuscript version 5
Publishing
16 Jan 2018 Editorially accepted
22 Jan 2018 Article published 10.1186/s12885-018-3999-0

You can find further information about peer review here.

Back to article page